Home > Drug Search >
  • company_query: Beijing Northland Biotech
  •   > 
Drug Filter
Category:
chemistry (10) biology (31)
Status:
BLA Filing (1) Phase Ⅲ (7) Phase Ⅱ (21) Phase Ⅰ (12)
Clinical Stage:
Pending (5) Active (32) Discontinued (4)
Bio-Type:
Gene therapy (5) Cell therapy (1) Vaccine (20) Recombinant enzyme (1) Recombinant polypeptide (1) Other recombinant protein (1) Whole antibody (1)
Indication:
Amyotrophic lateral sclerosis (ALS) (2) Breast cancer (2) Candidiasis (2) Chronic lymphocytic leukemia (CLL) (1) ischaemic heart disorder (1) Community-acquired pneumonia (CAP) (1) Cystic fibrosis (CF) (1) Dementia (1) Bronchitis (1) Diabetic nephropathy (1) Infections of the eye (1) Endometrial cancer (1) Pancreatitis (1) HBV infection (1) HCV infection (1) Head lice infestation (1) Heart failure (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Influenza virus infection (1) Lymphoma (1) Melanoma (2) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Pancreatic cancer (1) Peripheral arterial disease (PAD) (1) Measles (1) Pulmonary arterial hypertension (1) Solid tumours (3) Thrombocytopenia (1) Leber congenital amaurosis (2) Shigella infection (1) Tuberculosis (2) Type 2 diabetes (1) Colorectal cancer (2) Mycoses (1) Pain (1) Systemic inflammatory response syndrome (SIRS) (1) Diabetes (1) Malaria (1) Type 1 diabetes (1) Hemophilia B (1) Septic shock (1) Staphylococcal infection (1) Glioblastoma (1) Enterovirus infection (1) Mesothelioma (2) Bacterial infection (1) Renal failure (1) Cervical dysplasia (1) Myocardia ischemia (1) Chronic fatigue syndrome (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top